Key Highlights
- The blood test measures levels of the protein p-tau217.
- It can predict Alzheimer's symptom onset within three to four years.
- The test may facilitate early intervention and personalized care.
- The p-tau217 protein indicates the buildup of amyloid and tau in the brain.



